CONMEDCNMD
About: Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
Employees: 4,000
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
5% more repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 106
0.06% more ownership
Funds ownership: 115.75% [Q1] → 115.81% (+0.06%) [Q2]
2% less funds holding
Funds holding: 293 [Q1] → 287 (-6) [Q2]
13% less capital invested
Capital invested by funds: $2.85B [Q1] → $2.47B (-$381M) [Q2]
14% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 43
47% less call options, than puts
Call options by funds: $4.18M | Put options by funds: $7.91M
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
Needham Mike Matson 50% 1-year accuracy 58 / 116 met price target | 54%upside $97 | Buy Reiterated | 4 Oct 2024 |
Piper Sandler Matt O'Brien 41% 1-year accuracy 16 / 39 met price target | 27%upside $80 | Overweight Maintained | 1 Aug 2024 |
Stifel Rick Wise 63% 1-year accuracy 17 / 27 met price target | 21%upside $76 | Buy Maintained | 1 Aug 2024 |
Wells Fargo Vik Chopra 0% 1-year accuracy 0 / 4 met price target | 13%upside $71 | Equal-Weight Maintained | 1 Aug 2024 |
Needham Mike Matson 50% 1-year accuracy 58 / 116 met price target | 54%upside $97 | Buy Maintained | 1 Aug 2024 |
Financial journalist opinion
Based on 7 articles about CNMD published over the past 30 days